Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour”, “SYH” or the “Company”) is pleased to announce plans for a major 2026 exploration campaign spanning several of ...

Skyharbour Resources Ltd. (TSX-V:SYH) (OTCQX:SYHBF) (Frankfurt:SC1P) (“Skyharbour”, “SYH” or the “Company”) is pleased to announce plans for a major 2026 exploration campaign spanning several of the ...

As the global data center and related power infrastructure build-out continues at an unprecedented pace, the magnitude of the ...

Industrial Logistics Properties Trust (ILPT) surges nearly 70% with FedEx-backed tenants and leasing growth outlook. Read ...

KMI reports 4Q25 financial results. KMI board of directors today approved a cash dividend of $0.2925 per share for 4Q25, payable on 2/17/26.

Morningstar outlines the benefits of the total portfolio approach and how it can improve a traditional 60/40 portfolio.

The proposed takeover of a small ASX-listed company is key to a much bigger global play to break China’s stranglehold on ...

Caravel Minerals has emerged as a key ASX copper opportunity, with the metal's price run thrusting a spotlight on the ...

Q4 2025 Earnings Call January 21, 2026 4:30 PM ESTCompany ParticipantsRichard Kinder - Executive Chairman of the ...

The Miami Foundation’s Collective Real Estate Ownership program has helped 30 small businesses owners go from renting their ...

Companies continue to be pressured to move away from the conglomerate model and toward simplified and targeted strategies and ...

GSK (GSK) has agreed to buy US-listed biotech RAPT Therapeutics (US: RAPT) for $58 a share, valuing the company at about $2.2bn (£1.6bn), as it bolsters its respiratory and immunology pipeline.